Multiplex Detection Immunoassay Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region:

Description

The global Multiplex Detection Immunoassay Market is set to witness substantial growth, with a projected value exceeding US$ 3.03 billion by 2024. The market's expansion is attributed to the increasing concerns about food contamination due to antibiotic residues and the adoption of rapid, cost-effective, and high-throughput screening methods for antibiotic residue detection. Additionally, immunoassays are gaining traction for evaluating environmental and food safety, further propelling the market's growth.

Rising Demand for Multiplex Detection Immunoassays

The Multiplex Detection Immunoassay Market is expected to experience moderate growth, primarily due to its wide range of applications compared to traditional detection assays. The market's growth is driven by the rising prevalence of chronic diseases like Alzheimer's and cancer, as well as the development of efficient methods for simultaneous and cost-effective measurement of multiple analytes in a single sample.

Factors Boosting Market Growth

Increased Prevalence of Foodborne Diseases: Quick and effective detection methods, such as immunoassays, are in high demand in the food sector to combat foodborne pathogens. The market benefits from the need for rapid detection technologies.
Rise in Point-of-care Testing: The demand for point-of-care diagnosis for initial screening in non-laboratory settings is significantly increasing, driven by patient convenience. Various point-of-care immunoassays are available to detect various diseases, contributing to market growth.
Multiplexing Technologies in Drug Development: Multiplex detection immunoassays offer a solution to the challenges of analyzing multiple biomarkers in drug development, reducing effort and costs. This adoption in drug development is expected to drive market growth.

Challenges Faced by the Market

High Cost of Equipment: The cost of equipment for multiplex assay testing is high, making it challenging for researchers and manufacturers to conduct tests cost-effectively. Strict quality control criteria for multiplex assays also pose challenges.

Impact of COVID-19

The COVID-19 pandemic has affected various industries, including healthcare. However, the demand for multiplex assays for COVID-19 diagnosis has positively impacted the market. Multiplex point-of-care assays for SARS-CoV-2 have contributed to market growth.

Competitive Landscape

The Multiplex Detection Immunoassay market is highly competitive, with major players like Bio-Rad Laboratories Inc., Thermo Fisher Scientific, and others leading the market. Key players are focused on research and development activities to expand the applications of multiplex detection immunoassay technologies.

Key Companies Profiled

Bio-Rad Laboratories Inc.
Thermo Fisher Scientific
EMD Millipore (Merck KGaA.
Becton, Dickinson and Company.
Microsynth AG
Quansys Biosciences Inc
QIAGEN N.V.
F. Hoffmann-La Roche Ltd.
Danaher Corporation.
Luminex Corporation

Multiplex Detection Immunoassay Market Categorization

Multiplex Detection Immunoassay Market By Technique

Nucleic Acid Based Technique
Protein Based Technique
Biosensor Based Technique

Multiplex Detection Immunoassay Market By Assay Type

Planar Assay

Blends Protein Arrays (Multiplexed ELISA)

Antibody Arrays

Bead-based Assay

Magnetic Bead-based

Non-magnetic Bead-based

Multiplex Detection Immunoassay Market By Application

Disease Testing

Infectious Disease Testing

Autoimmune Disease Testing

Other Diseases Testing

Food Contamination Testing
Research and Development
Veterinary Disease Testing

Multiplex Detection Immunoassay Market By End User

Pharmaceutical Companies
Clinical Research Organizations
Food & Beverages Companies
Academic Research Institutes
Diagnostic Centers
Biotechnology Centers

Multiplex Detection Immunoassay Market By Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)

1. Executive Summary

1.1. Global Multiplex Detection Immunoassay Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Multiplex Detection Immunoassay Market Outlook, 2018 - 2031

3.1. Global Multiplex Detection Immunoassay Market Outlook, by Technique, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Nucleic Acid Based Technique
  - 3.1.1.2. Protein Based Technique
  - 3.1.1.3. Biosensor Based Technique
3.2. Global Multiplex Detection Immunoassay Market Outlook, by Assay Type, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Planar Assay
    - 3.2.1.1.1. Blends Protein Arrays (Multiplexed ELISA)
    - 3.2.1.1.2. Antibody Arrays
  - 3.2.1.2. Bead-based Assay
    - 3.2.1.2.1. Magnetic Bead-based
    - 3.2.1.2.2. Non-magnetic Bead-based
3.3. Global Multiplex Detection Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Disease Testing
    - 3.3.1.1.1. Infectious Disease Testing
    - 3.3.1.1.2. Autoimmune Disease Testing
    - 3.3.1.1.3. Other Diseases Testing
  - 3.3.1.2. Food Contamination Testing
  - 3.3.1.3. Research and Development
  - 3.3.1.4. Veterinary Disease Testing
3.4. Global Multiplex Detection Immunoassay Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. Pharmaceutical Companies
  - 3.4.1.2. Clinical Research Organizations
  - 3.4.1.3. Food & Beverages Companies
  - 3.4.1.4. Academic Research Institutes
  - 3.4.1.5. Diagnostic Centres
  - 3.4.1.6. Biotechnology Centres
3.5. Global Multiplex Detection Immunoassay Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.5.1. Key Highlights
  - 3.5.1.1. North America
  - 3.5.1.2. Europe
  - 3.5.1.3. Asia Pacific
  - 3.5.1.4. Latin America
  - 3.5.1.5. Middle East & Africa

4. North America Multiplex Detection Immunoassay Market Outlook, 2018 - 2031

4.1. North America Multiplex Detection Immunoassay Market Outlook, by Technique, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Nucleic Acid Based Technique
  - 4.1.1.2. Protein Based Technique
  - 4.1.1.3. Biosensor Based Technique
4.2. Global Multiplex Detection Immunoassay Market Outlook, by Assay Type, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Planar Assay
    - 4.2.1.1.1. Blends Protein Arrays (Multiplexed ELISA)
    - 4.2.1.1.2. Antibody Arrays
  - 4.2.1.2. Bead-based Assay
    - 4.2.1.2.1. Magnetic Bead-based
    - 4.2.1.2.2. Non-magnetic Bead-based
4.3. North America Multiplex Detection Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Disease Testing
    - 4.3.1.1.1. Infectious Disease Testing
    - 4.3.1.1.2. Autoimmune Disease Testing
    - 4.3.1.1.3. Other Diseases Testing
  - 4.3.1.2. Food Contamination Testing
  - 4.3.1.3. Research and Development
  - 4.3.1.4. Veterinary Disease Testing
4.4. North America Multiplex Detection Immunoassay Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. Pharmaceutical Companies
  - 4.4.1.2. Clinical Research Organizations
  - 4.4.1.3. Food & Beverages Companies
  - 4.4.1.4. Academic Research Institutes
  - 4.4.1.5. Diagnostic Centres
  - 4.4.1.6. Biotechnology Centres
4.5. North America Multiplex Detection Immunoassay Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.5.1. Key Highlights
  - 4.5.1.1. U.S. Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 4.5.1.2. U.S. Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.3. U.S. Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.4. U.S. Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.5.1.5. Canada Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 4.5.1.6. Canada Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 4.5.1.7. Canada Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.5.1.8. Canada Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
- 4.5.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Multiplex Detection Immunoassay Market Outlook, 2018 - 2031

5.1. Europe Multiplex Detection Immunoassay Market Outlook, by Technique, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Nucleic Acid Based Technique
  - 5.1.1.2. Protein Based Technique
  - 5.1.1.3. Biosensor Based Technique
5.2. Europe Multiplex Detection Immunoassay Market Outlook, by Assay Type, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Planar Assay
    - 5.2.1.1.1. Blends Protein Arrays (Multiplexed ELISA)
    - 5.2.1.1.2. Antibody Arrays
  - 5.2.1.2. Bead-based Assay
    - 5.2.1.2.1. Magnetic Bead-based
    - 5.2.1.2.2. Non-magnetic Bead-based
5.3. Europe Multiplex Detection Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Disease Testing
    - 5.3.1.1.1. Infectious Disease Testing
    - 5.3.1.1.2. Autoimmune Disease Testing
    - 5.3.1.1.3. Other Diseases Testing
  - 5.3.1.2. Food Contamination Testing
  - 5.3.1.3. Research and Development
  - 5.3.1.4. Veterinary Disease Testing
5.4. Europe Multiplex Detection Immunoassay Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Pharmaceutical Companies
  - 5.4.1.2. Clinical Research Organizations
  - 5.4.1.3. Food & Beverages Companies
  - 5.4.1.4. Academic Research Institutes
  - 5.4.1.5. Diagnostic Centres
  - 5.4.1.6. Biotechnology Centres
5.5. Europe Multiplex Detection Immunoassay Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.5.1. Key Highlights
  - 5.5.1.1. Germany Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 5.5.1.2. Germany Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.3. Germany Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.4. Germany Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.5. U.K. Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 5.5.1.6. U.K. Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.7. U.K. Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.8. U.K. Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.9. France Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 5.5.1.10. France Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.11. France Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.12. France Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.13. Italy Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 5.5.1.14. Italy Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.15. Italy Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.16. Italy Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.17. Turkey Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 5.5.1.18. Turkey Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.19. Turkey Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.20. Turkey Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.21. Russia Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 5.5.1.22. Russia Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.23. Russia Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.24. Russia Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.5.1.25. Rest of Europe Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 5.5.1.26. Rest of Europe Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 5.5.1.27. Rest of Europe Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.5.1.28. Rest of Europe Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
- 5.5.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Multiplex Detection Immunoassay Market Outlook, 2018 - 2031

6.1. Asia Pacific Multiplex Detection Immunoassay Market Outlook, by Technique, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Nucleic Acid Based Technique
  - 6.1.1.2. Protein Based Technique
  - 6.1.1.3. Biosensor Based Technique
6.2. Asia Pacific Multiplex Detection Immunoassay Market Outlook, by Assay Type, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Planar Assay
    - 6.2.1.1.1. Blends Protein Arrays (Multiplexed ELISA)
    - 6.2.1.1.2. Antibody Arrays
  - 6.2.1.2. Bead-based Assay
    - 6.2.1.2.1. Magnetic Bead-based
    - 6.2.1.2.2. Non-magnetic Bead-based
6.3. Asia Pacific Multiplex Detection Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Disease Testing
    - 6.3.1.1.1. Infectious Disease Testing
    - 6.3.1.1.2. Autoimmune Disease Testing
    - 6.3.1.1.3. Other Diseases Testing
  - 6.3.1.2. Food Contamination Testing
  - 6.3.1.3. Research and Development
  - 6.3.1.4. Veterinary Disease Testing
6.4. Asia Pacific Multiplex Detection Immunoassay Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. Pharmaceutical Companies
  - 6.4.1.2. Clinical Research Organizations
  - 6.4.1.3. Food & Beverages Companies
  - 6.4.1.4. Academic Research Institutes
  - 6.4.1.5. Diagnostic Centres
  - 6.4.1.6. Biotechnology Centres
6.5. Asia Pacific Multiplex Detection Immunoassay Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.5.1. Key Highlights
  - 6.5.1.1. China Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 6.5.1.2. China Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.3. China Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.4. China Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.5. Japan Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 6.5.1.6. Japan Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.7. Japan Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.8. Japan Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.9. South Korea Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 6.5.1.10. South Korea Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.11. South Korea Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.12. South Korea Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.13. India Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 6.5.1.14. India Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.15. India Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.16. India Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.17. Southeast Asia Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 6.5.1.18. Southeast Asia Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.19. Southeast Asia Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.20. Southeast Asia Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.5.1.21. Rest of Asia Pacific Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 6.5.1.22. Rest of Asia Pacific Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 6.5.1.23. Rest of Asia Pacific Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.5.1.24. Rest of Asia Pacific Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
- 6.5.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Multiplex Detection Immunoassay Market Outlook, 2018 - 2031

7.1. Latin America Multiplex Detection Immunoassay Market Outlook, by Technique, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Nucleic Acid Based Technique
  - 7.1.1.2. Protein Based Technique
  - 7.1.1.3. Biosensor Based Technique
7.2. Latin America Multiplex Detection Immunoassay Market Outlook, by Assay Type, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Planar Assay
    - 7.2.1.1.1. Blends Protein Arrays (Multiplexed ELISA)
    - 7.2.1.1.2. Antibody Arrays
  - 7.2.1.2. Bead-based Assay
    - 7.2.1.2.1. Magnetic Bead-based
    - 7.2.1.2.2. Non-magnetic Bead-based
7.3. Latin America Multiplex Detection Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Disease Testing
    - 7.3.1.1.1. Infectious Disease Testing
    - 7.3.1.1.2. Autoimmune Disease Testing
    - 7.3.1.1.3. Other Diseases Testing
  - 7.3.1.2. Food Contamination Testing
  - 7.3.1.3. Research and Development
  - 7.3.1.4. Veterinary Disease Testing
7.4. Latin America Multiplex Detection Immunoassay Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Pharmaceutical Companies
  - 7.4.1.2. Clinical Research Organizations
  - 7.4.1.3. Food & Beverages Companies
  - 7.4.1.4. Academic Research Institutes
  - 7.4.1.5. Diagnostic Centres
  - 7.4.1.6. Biotechnology Centres
7.5. Latin America Multiplex Detection Immunoassay Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.5.1. Key Highlights
  - 7.5.1.1. Brazil Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 7.5.1.2. Brazil Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.3. Brazil Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.4. Brazil Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.5. Mexico Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 7.5.1.6. Mexico Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.7. Mexico Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.8. Mexico Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.9. Argentina Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 7.5.1.10. Argentina Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.11. Argentina Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.12. Argentina Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.5.1.13. Rest of Latin America Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 7.5.1.14. Rest of Latin America Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 7.5.1.15. Rest of Latin America Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.5.1.16. Rest of Latin America Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
- 7.5.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Multiplex Detection Immunoassay Market Outlook, 2018 - 2031

8.1. Middle East & Africa Multiplex Detection Immunoassay Market Outlook, by Technique, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Nucleic Acid Based Technique
  - 8.1.1.2. Protein Based Technique
  - 8.1.1.3. Biosensor Based Technique
8.2. Middle East & Africa Multiplex Detection Immunoassay Market Outlook, by Assay Type, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Planar Assay
    - 8.2.1.1.1. Blends Protein Arrays (Multiplexed ELISA)
    - 8.2.1.1.2. Antibody Arrays
  - 8.2.1.2. Bead-based Assay
    - 8.2.1.2.1. Magnetic Bead-based
    - 8.2.1.2.2. Non-magnetic Bead-based
8.3. Middle East & Africa Multiplex Detection Immunoassay Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Disease Testing
    - 8.3.1.1.1. Infectious Disease Testing
    - 8.3.1.1.2. Autoimmune Disease Testing
    - 8.3.1.1.3. Other Diseases Testing
  - 8.3.1.2. Food Contamination Testing
  - 8.3.1.3. Research and Development
  - 8.3.1.4. Veterinary Disease Testing
8.4. Middle East & Africa Multiplex Detection Immunoassay Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. Pharmaceutical Companies
  - 8.4.1.2. Clinical Research Organizations
  - 8.4.1.3. Food & Beverages Companies
  - 8.4.1.4. Academic Research Institutes
  - 8.4.1.5. Diagnostic Centres
  - 8.4.1.6. Biotechnology Centres
8.5. Middle East & Africa Multiplex Detection Immunoassay Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.5.1. Key Highlights
  - 8.5.1.1. GCC Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 8.5.1.2. GCC Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.3. GCC Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.4. GCC Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.5. South Africa Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 8.5.1.6. South Africa Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.7. South Africa Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.8. South Africa Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.9. Egypt Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 8.5.1.10. Egypt Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.11. Egypt Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.12. Egypt Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.13. Nigeria Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 8.5.1.14. Nigeria Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.15. Nigeria Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.16. Nigeria Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.5.1.17. Rest of Middle East & Africa Multiplex Detection Immunoassay Market by Technique, Value (US$ Bn), 2018 - 2031
  - 8.5.1.18. Rest of Middle East & Africa Multiplex Detection Immunoassay Market by Assay Type, Value (US$ Bn), 2018 - 2031
  - 8.5.1.19. Rest of Middle East & Africa Multiplex Detection Immunoassay Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.5.1.20. Rest of Middle East & Africa Multiplex Detection Immunoassay Market by End User, Value (US$ Bn), 2018 - 2031
- 8.5.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. By Technique vs By Assay Type Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Bio-Rad Laboratories Inc.
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Thermo Fisher Scientific
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. EMD Millipore (Merck KGaA.
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. Becton, Dickinson and Company.
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Microsynth AG
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. Quansys Biosciences Inc
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. QIAGEN N.V.
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. F. Hoffmann-La Roche Ltd.
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Danaher Corporation.
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. Luminex Corporation
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations